Description
Semaglutide in Kenya is a medication used to manage type 2 diabetes and support weight loss. It works by mimicking a natural hormone called GLP-1, which helps regulate blood sugar levels by increasing insulin release, reducing sugar production by the liver, and slowing stomach emptying. This combination also reduces appetite, making it effective for weight management. Semaglutide is available under brand names like Ozempic® (for diabetes), Wegovy® (for weight loss), Sema-q and Rybelsus® (oral form for diabetes).
The medication is typically taken once weekly as an injection or once daily in tablet form. Common side effects include nausea, vomiting, diarrhea, and decreased appetite. It is not recommended for people with type 1 diabetes or those with a history of medullary thyroid cancer or pancreatitis. Semaglutide is a valuable option for patients needing improved blood sugar control and long-term weight management, but it should always be used under medical supervision.
Reviews
There are no reviews yet.